Highlights of API Form and solid state services
Serving over 1000 clients worldwide
Supported solid form screening, crystallization, and preclinical formulation development of over 2,000 new drug molecules
The world's leading technology supports the understandingof molecule and formulation with a high-end platform
High-quality service, a culture of confidentiality, and fast turnaround with cost-effective pricing
Customized solution for your molecule, spanning the entire drug lifecycle
API Form and solid state chemistry services
Solid Form Screening and Selection
Solid form is a general term that refers to both crystalline and amorphous materials. The solid form will impact active pharmaceutical ingredient (API) development properties such as solubility, dissolution rate, stability, hygroscopicity, and bioavailability.
Absolute Structure Determination
Single crystal growth and structure determination technology are the main methods to determine the absolute configuration of drug molecules and identify the crystal forms absolutely. The single crysta...
Solid-State NMR Analysis
Nuclear Magnetic Resonance (NMR) Spectroscopy is a ubiquitous analytical technique utilized across a wide range of disciplines.
Our Experience Becomes Your Competitive Advantages
Data Quality & Intellectual Protection
Project Management
Scientific Oriented
Flexibility
Effiency
Location
Labs in USA,Canada& China
Convenience and Flexbility
Cost Effective
Experience
Experienced Project Team
Scientific BD member
For more information about solid state research and contract manufacturing organization pharma, please feel free to contact us!
Crystal pharma sau, established in 2010, is a global company with approximately 250 employees and three R&D centers located in Suzhou (China), New Jersey (USA), and Toronto (Canada). Our key differentiator is our integrated and specialized services, including API solid-state research, crystallization, preformulation, formulation development and manufacturing, clinical supply.